Long-term Follow-up Study for Patients Treated with Genetically Modified T Cells

Program Overview

The study aims to keep track of patients who have undergone a treatment involving genetically modified T cells, known as AUTO CAR T cell therapy, for up to 15 years. Researchers will be looking for any delayed side effects, new health issues, or changes in the effectiveness of the treatment over time. This long-term monitoring will help determine the overall safety and benefits of the therapy.

Description

This study focuses on following patients who have received AUTO CAR T cell therapy, a treatment that uses a patient's own T cells that have been genetically modified to fight cancer. Over the course of up to 15 years, researchers will monitor these patients to check for any long-term side effects, such as serious adverse events or new health conditions that might arise from the treatment. They will also look for any signs of new viruses or cancers that could be linked to the therapy. Additionally, the study will assess how long the modified T cells remain active in the body and how effective they continue to be in fighting cancer. This information will help doctors better understand the risks and benefits of AUTO CAR T cell therapy in the long run.

Eligibility Criteria

Locations